Patents by Inventor Orna Goren

Orna Goren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8361458
    Abstract: Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: January 29, 2013
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Beka Solomon, Orna Goren
  • Publication number: 20110142803
    Abstract: Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits.
    Type: Application
    Filed: December 13, 2010
    Publication date: June 16, 2011
    Applicant: Ramot At Tel-Aviv University LTD.
    Inventors: Beka SOLOMON, Orna GOREN
  • Patent number: 7867487
    Abstract: Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: January 11, 2011
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Beka Solomon, Orna Goren
  • Publication number: 20090180991
    Abstract: Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits.
    Type: Application
    Filed: January 31, 2006
    Publication date: July 16, 2009
    Applicant: Ramot At Tel-Aviv University Ltd.
    Inventors: Beka Solomon, Orna Goren